stockrowAtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) Net income
AtriCure, Inc.'s net income for fiscal 2025 was −$11.4M, compared with −$44.7M in fiscal 2024. Over the twelve months to 30 September 2026 it was $14.9M. Over the past ten years it has ranged from −$48.2M (fiscal 2020) to $50.2M (fiscal 2021); the current reading is higher than 91% of that period. AtriCure, Inc. ranks 19th of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$11.4M | — |
| FY2024 | −$44.7M | — |
| FY2023 | −$30.4M | — |
| FY2022 | −$46.5M | — |
| FY2021 | $50.2M | — |
| FY2020 | −$48.2M | — |
| FY2019 | −$35.2M | — |
| FY2018 | −$21.1M | — |
| FY2017 | −$26.9M | — |
| FY2016 | −$33.3M | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $9.0M | 8,191.67% |
| Mar 2026 | $108.0K | (93.85%) |
| Dec 2025 | $1.8M | — |
| Sep 2025 | −$267.0K | — |
| 42 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| NVST Envista Holdings Corporation compare | $633.6M |
| STVN Stevanato Group S.p.A. compare | $227.4M |
| MMSI Merit Medical Systems, Inc. compare | $160.1M |
| ICUI ICU Medical, Inc. compare | $60.3M |
| ATRC AtriCure, Inc. | $14.9M |
| WRBY Warby Parker Inc. compare | $7.5M |
| PLSE Pulse Biosciences, Inc compare | −$83.8M |
| XRAY DENTSPLY SIRONA Inc. compare | −$122.0M |
| MMED MiniMed Group, Inc. compare | −$320.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on ATRC
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement